Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Panavance Therapeutics Inc. logo — We are a clinical-stage pharmaceutical company focused on im...

Panavance Therapeutics Inc.

We are a clinical-stage pharmaceutical company focused on improving the outcomes and lives of cancer patients.

Founded 2021 United States Berwyn, United States 9 employees Health and Wellness, Pharmaceutical

General Information

Company Name Panavance Therapeutics Inc.
Founded Year 2021
Location United States Berwyn, United States +1
Employees 9
Industries Health and Wellness, Pharmaceutical
Social

Get notified when Panavance Therapeutics Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Panavance Therapeutics Inc.

Panavance Therapeutics Inc. is a clinical-stage pharmaceutical company with a clear mission to improve the outcomes and lives of cancer patients. Established in 2021, Panavance is backed by the Swiss-based Avensis Pharma AG, a subsidiary of Ed. Geistlich Söhne AG für Chemische Industrie. The company's primary focus lies in advancing the development of GP-2250, a novel oncology therapeutic designed to enhance the outcomes and quality of life for cancer patients. With a strong emphasis on collaboration, Panavance has forged robust partnerships within both academic and industry circles, positioning the company to pursue an extensive program aimed at making GP-2250 accessible to patients globally. While specific details regarding the company's headquarters and previous investments are currently unavailable, Panavance's dedication to advancing cancer therapeutics underlines its potential as a strategic investment opportunity within the Health and Wellness and Pharmaceutical industries.

Taxonomy: Clinical-stage pharmaceuticals, Oncology therapeutics, Cancer treatment, GP-2250, Research and development, Pharmaceutical partnerships, Clinical trials, Medical research, Quality of life improvement, Cancer patient outcomes, Industry partnerships

No funding data available for Panavance Therapeutics Inc. yet.

Get notified when Panavance Therapeutics Inc. raises funding

Panavance Therapeutics Inc. Alternatives & Competitors

Panavance Therapeutics Inc. vs
HealthTree Foundation
HealthTree Foundation United States

The HealthTree Foundation provides blood cancer disease navigation tools for patients that also acce...

74 employees
Health Care
Panavance Therapeutics Inc. vs
Cure Leukaemia
Cure Leukaemia United Kingdom

We fund the Trials Acceleration Programme (TAP) which delivers & connects patients to blood cancer c...

23 employees
Health Care
Panavance Therapeutics Inc. vs
Unicancer
Unicancer France

We are the only French hospital network 100% dedicated to the fight against cancer.

355 employees
Health Care

FAQ About Panavance Therapeutics Inc.

We are a clinical-stage pharmaceutical company focused on improving the outcomes and lives of cancer patients.
Panavance Therapeutics Inc. was founded in 2021.
Panavance Therapeutics Inc. is headquartered in Berwyn, United States.
Panavance Therapeutics Inc. operates in the following industries: Health and Wellness, Pharmaceutical.
Panavance Therapeutics Inc. has approximately 9 employees.
Top alternatives and competitors to Panavance Therapeutics Inc. include HealthTree Foundation , Cure Leukaemia, Unicancer, Madison Vaccines, EORTC - European Organisation for Research and Treatment of Cancer. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Panavance Therapeutics Inc. and HealthTree Foundation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Panavance Therapeutics Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes